Keryx Biopharmaceuticals, Inc. Pre-Tax Profit Margin 2010-2018 | KERX
Keryx Biopharmaceuticals, Inc. pre-tax profit margin from 2010 to 2018. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2018-09-30 | $0.10B | $-0.09B | -97.89% |
| 2018-06-30 | $0.08B | $-0.10B | -120.73% |
| 2018-03-31 | $0.07B | $-0.16B | -229.58% |
| 2017-12-31 | $0.06B | $-0.16B | -267.21% |
| 2017-09-30 | $0.05B | $-0.17B | -319.23% |
| 2017-06-30 | $0.04B | $-0.19B | -430.23% |
| 2017-03-31 | $0.04B | $-0.14B | -389.19% |
| 2016-12-31 | $0.03B | $-0.16B | -506.25% |
| 2016-09-30 | $0.03B | $-0.17B | -592.86% |
| 2016-06-30 | $0.03B | $-0.16B | -596.15% |
| 2016-03-31 | $0.02B | $-0.14B | -685.00% |
| 2015-12-31 | $0.01B | $-0.12B | -885.71% |
| 2015-09-30 | $0.01B | $-0.13B | -1400.00% |
| 2015-06-30 | $0.01B | $-0.13B | -2600.00% |
| 2014-12-31 | $0.01B | $-0.11B | -1009.09% |
| 2009-12-31 | $0.03B | $0.01B | 40.00% |
